Public Company News

Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY

SHANGHAI, March 24, 2025 /PRNewswire/ -- Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximatelyRMB5.7244 billion, representing an increase of 6.1% YoY. The net profit reachedRMB820.5 million, a 50.3% YoY growth, with a net pr...

2025-03-24 22:54 4241

WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024

* Revenue increased by 90.8% YoY to RMB 4,052 million * Gross profit grew by 121.6% YoY to RMB 1,240 million, with its margin of 30.6%, a 4.3 percentage points increase compared to that of 2023 * Net profit surged by 277.2% YoY to RMB 1,070 million, with its margin of 26.4%, a 13.0 percentag...

2025-03-24 22:45 4489

Getac Honored in the 2025 CRN Partner Program Guide

Rugged Technology Solutions Provider Recognized for a Commitment to Enhancing Partner Profitability and Success IRVINE, Calif., March 24, 2025 /PRNewswire/ -- Getac Technology Corporation  (Getac), a leading provider of rugged computing and mobile video solutions, has ...

2025-03-24 22:00 2577

Amcor Lift-Off initiative extends deadline for compostable or recyclable barrier coating solution challenge

ZURICH, March 24, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging solutions, announced the extension of the application period for a new challenge under its Amcor Lift-Off initiative, the Amcor Lift-Off Sprints. The challenge ai...

2025-03-24 21:22 3120

Cloopen Files Annual Report on Form 20-F for Fiscal 2023

BEIJING, March 24, 2025 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that it filed its annual report on Form 20-F (the "Annual Report") for the fiscal year endedDecember 31, 2023 with the U.S. Securities and Exchange Commission (the "SEC"...

2025-03-24 21:22 4185

Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval

NEW YORK, March 24, 2025 /PRNewswire/ -- On March 17, 2025, US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical—an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., Ltd. (SH.688068)—received Fast Track Des...

2025-03-24 21:00 2119

Julius by Triller launch Influencer Marketing Report 2025

New report reveals the top influencer marketing strategies shaping the future of brand partnerships LOS ANGELES, March 24, 2025 /PRNewswire/ -- As influencer marketing continues to evolve, brands must adapt to changing audience behaviors and emerging industry trends. Today, Julius by Triller, an...

2025-03-24 21:00 3168

NYSE Content advisory: Pre-Market update + Liberty Energy's New CEO to ring the bell

NEW YORK, March 24, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    Pre-Market update + Liberty Energy’s New CEO to ring the bell K...

2025-03-24 20:55 2479

Farmmi, Inc. Announces Expansion into the U.S. East Coast Market with New Warehouse in New Jersey

LISHUI, China, March 24, 2025 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI) today announced that the Company has expanded its U.S. logistics and warehousing operations to the East Coast market. This significant milestone marks the Company's business expansion from the We...

2025-03-24 20:30 4214

NYSE CONTENT ADVISORY: The NYSE on the ground at HumanX's inaugural AI conference

NEW YORK, March 24, 2025 /PRNewswire/ -- As a leading global exchange, the NYSE is committed to empowering our diverse communities, wherever they may be. Engaging with our listed companies and emerging startups at key industry events is an opportunity to do just that. Experience the full interac...

2025-03-24 20:15 2930

TROOPS, Inc. (Nasdaq: TROO) Explores Acquisition of Hong Kong Insurance Brokerage and Nears Agreement to Acquire Bestfaith International Technology Limited

Strategic Moves to Expand Footprint in Hong Kong's Real Estate and Insurance Sectors HONG KONG, March 24, 2025 /PRNewswire/ -- TROOPS, Inc. (Nasdaq: TROO) (the "Company" or "TROOPS") today announced two strategic initiatives to accelerate its growth inAsia. The Company has commenced preliminary ...

2025-03-24 19:40 3835

U Power Limited (Nasdaq: UCAR) Announces Landmark Joint Venture with SUSCO, Targeting Thailand's Multi-Billion EV Infrastructure Boom

Strategic Partnership to Address Rapid EV Growth Driven by Government Policy Changes inThailand SHANGHAI, March 24, 2025 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR), a world leader in rapid battery swapping technology for EV's, ("U Power" or the "Company") announced today that it has signed a...

2025-03-24 19:00 3976

Electrolux Group announces industry-leading target in its latest sustainability reporting

STOCKHOLM, March 24, 2025 /PRNewswire/ -- Today Electrolux Group announces a new ambitious recycled materials target, which aims to increase the share of recycled steel and plastic by weight used in the products manufactured by the Group to 35% by 2030. This almost doubles the weight of recycled ...

2025-03-24 15:23 2359

Seeing Machines announces new technology and safety appointments

CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE, "Seeing Machines" or the "Company"), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, is pleased to announce the appointment ofJoh...

2025-03-24 15:00 3743

APsystems at 15: A Legacy of Innovation and a Smart Energy Future

JIAXING, China, March 24, 2025 /PRNewswire/ -- Fifteen years ago today, on March 24, 2010, APsystems was founded in Jiaxing, Zhejiang, embarking on a mission to harness the power of light. Over the past 15 years, APsystems has transformed from a hardware supplier specializing in MLPE microinverte...

2025-03-24 12:00 5115

HKEX Welcomes Asia's First Single Stock L&I Products

* HKEX is the first exchange in Asia to offer Single Stock L&I Products * ETP market ADT up 89% at HK$36 billion in Jan-Feb 2025 HONG KONG, March 24, 2025 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) is pleased to welcome today (Monday) the listing ofAsia's first Single Stoc...

2025-03-24 11:00 4411

Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation

HONG KONG, March 23, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced on March 21st, 2025 its financial results for fiscal year 2024, reporting total revenue ofRMB 2.7 billion, representing an 11.2% year-over-year inc...

2025-03-24 11:00 3496

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

SUZHOU, China, March 23, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the European Medicines Agency (EMA) for sugemalimab. T...

2025-03-24 08:15 3653

AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates

HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onMarch 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial approval from the U.S. Food and Drug Administrati...

2025-03-24 08:00 3239

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2025-03-24 08:00 3413

Week's Top Stories